159 related articles for article (PubMed ID: 2748873)
1. Common side effects associated with monoamine oxidase inhibitors.
Remick RA; Froese C; Keller FD
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
[TBL] [Abstract][Full Text] [Related]
2. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
Goff DC
Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
[TBL] [Abstract][Full Text] [Related]
3. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
Rabkin JG; Quitkin FM; McGrath P; Harrison W; Tricamo E
J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
[TBL] [Abstract][Full Text] [Related]
6. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
Nolen WA
Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
[TBL] [Abstract][Full Text] [Related]
7. Severe daytime somnolence in patients treated with an MAOI.
Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
[TBL] [Abstract][Full Text] [Related]
8. Switching monoamine oxidase inhibitors.
True BL; Alexander B; Carter B
Drug Intell Clin Pharm; 1985 Nov; 19(11):825-7. PubMed ID: 4064915
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitor-induced speech blockage.
Goldstein DM; Goldberg RL
J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
[TBL] [Abstract][Full Text] [Related]
11. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
Ketter TA; Post RM; Parekh PI; Worthington K
J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
[TBL] [Abstract][Full Text] [Related]
12. MAOIs - does the evidence warrant their resurrection?
Menkes D; Bosanac P; Castle D
Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
[TBL] [Abstract][Full Text] [Related]
13. MAOIs in the contemporary treatment of depression.
Thase ME; Trivedi MH; Rush AJ
Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
[TBL] [Abstract][Full Text] [Related]
14. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
15. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
[TBL] [Abstract][Full Text] [Related]
16. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
Durmuş B; Osse RJ; Emmer B; van Kooten F
Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
[No Abstract] [Full Text] [Related]
17. Mysterious MAOI hypertensive episodes.
Kahn D
J Clin Psychiatry; 1988 Jan; 49(1):38-9. PubMed ID: 3335491
[No Abstract] [Full Text] [Related]
18. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
Fallon B; Foote B; Walsh BT; Roose SP
J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
[TBL] [Abstract][Full Text] [Related]
19. Refractory depression treated with high doses of monoamine oxidase inhibitor.
Guze BH; Baxter LR; Rego J
J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
[TBL] [Abstract][Full Text] [Related]
20. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
